BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12057699)

  • 21. Bronchiolitis obliterans syndrome: utility of the new guidelines in single lung transplant recipients.
    Nathan SD; Barnett SD; Wohlrab J; Burton N
    J Heart Lung Transplant; 2003 Apr; 22(4):427-32. PubMed ID: 12681420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
    Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
    J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
    Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM
    Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decline in 25% to 75% forced expiratory flow as an early predictor of chronic airway rejection in pediatric lung transplant recipients.
    Rosen JB; Smith EO; Schecter MG; Mallory GB; Elidemir O
    J Heart Lung Transplant; 2012 Dec; 31(12):1288-92. PubMed ID: 23102913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome.
    Fiser SM; Tribble CG; Long SM; Kaza AK; Kern JA; Jones DR; Robbins MK; Kron IL
    Ann Thorac Surg; 2002 Apr; 73(4):1041-7; discussion 1047-8. PubMed ID: 11996238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
    Hadjiliadis D; Davis RD; Palmer SM
    Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchiolitis obliterans syndrome in single lung transplant recipients--patients with emphysema versus patients with idiopathic pulmonary fibrosis.
    Haider Y; Yonan N; Mogulkoc N; Carroll KB; Egan JJ
    J Heart Lung Transplant; 2002 Mar; 21(3):327-33. PubMed ID: 11897520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
    Manuel O; Kumar D; Moussa G; Chen MH; Pilewski J; McCurry KR; Studer SM; Crespo M; Husain S; Humar A
    Transplantation; 2009 Mar; 87(5):719-25. PubMed ID: 19295317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of mean transit time in the engrafted lung with 133Xe lung ventilation scintigraphy improves diagnosis of bronchiolitis obliterans syndrome in living-donor lobar lung transplant recipients.
    Shinya T; Sato S; Kato K; Gobara H; Akaki S; Date H; Kanazawa S
    Ann Nucl Med; 2008 Jan; 22(1):31-9. PubMed ID: 18250985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obliterative bronchiolitis following lung transplantation: from old to new concepts?
    Verleden GM; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Verleden SE; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
    Transpl Int; 2009 Aug; 22(8):771-9. PubMed ID: 19490538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?
    Nørgaard MA; Andersen CB; Pettersson G
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):311-8. PubMed ID: 9761443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.
    Ruttens D; Verleden SE; Demeyer H; Van Raemdonck DE; Yserbyt J; Dupont LJ; Vanaudenaerde BM; Vos R; Verleden GM
    PLoS One; 2018; 13(4):e0193564. PubMed ID: 29624575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation.
    Engelmann I; Welte T; Fühner T; Simon AR; Mattner F; Hoy L; Schulz TF; Gottlieb J
    J Clin Virol; 2009 May; 45(1):47-53. PubMed ID: 19303808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome.
    Brugière O; Thabut G; Mal H; Marceau A; Dauriat G; Marrash-Chahla R; Castier Y; Lesèche G; Colombat M; Fournier M
    Eur Respir J; 2005 May; 25(5):813-9. PubMed ID: 15863637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchiolitis obliterans and lung transplantation: evidence for an infectious etiology.
    Husain S; Singh N
    Semin Respir Infect; 2002 Dec; 17(4):310-4. PubMed ID: 12497548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation.
    Ensor CR; Rihtarchik LC; Morrell MR; Hayanga JW; Lichvar AB; Pilewski JM; Wisniewski S; Johnson BA; D'Cunha J; Zeevi A; McDyer JF
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28008661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Forced Expiratory Volume in 1 Second (FEV1) and 6-Minute Walking Distance at 3, 6, and 12 Months and Annually on Survival and Occurrence of Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation.
    Fakhro M; Ingemansson R; Algotsson L; Lindstedt S
    Ann Transplant; 2017 Sep; 22():532-540. PubMed ID: 28871078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
    Morrell MR; Despotis GJ; Lublin DM; Patterson GA; Trulock EP; Hachem RR
    J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.